NASDAQ · TBRG
TruBridge, Inc.
Healthcare · Medical - Healthcare Information Services
$26.240.00% ($0.00)at close
As of 4:00 PM ET
Valuation
Revenue & margin DCF
Verdict: fairly priced. Price above Base.
The price needs 7.8% revenue growth a year for 10 years. Our scenarios assume 0.9–4.4%.
That's 1.4× its past 4-year pace.
Value per share
Base case
$13.38
Price used $26.24 is 2.0× this
USD · TTM ending Mar 31, 2026 · Price Jul 8, 8:00 PM UTC
Revenue each value needs
Revenue today $346M. The price needs $732M by 2036. Base case: $389M. At its recent pace: $587M. Bear to Bull: $377M to $532M.
Revenue today $346M. The price needs $732M by 2036. Base case: $389M. At its recent pace: $587M. Bear to Bull: $377M to $532M.
Revenue in 2036
today $346M
+$343Mmore than the Base case · 1.9×
Value per share · Base case
$13.38
Price $26.24
2.0× this
- 10-yr revenue CAGR
- 1.2%
- Ending operating margin
- 6.0%
- Discount rate
- 9.2%
USD · TTM ending Mar 31, 2026 · Price Jul 8, 8:00 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
Why The Stock Is Moving
Note: The latest financial period used here ended about 7 months ago, so a newer report is probably out. Metrics shown may not reflect it.
What changed
The stock rose 19.65% over the last year. Revenue declined 0.45% over the trailing twelve months. Operating margin moved from 4.93% to 5.96%. Free cash flow grew 95.13% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 25th percentile of their historical P/FCF range.
What would invalidate this read
Operating margin is at 5.96%. Revenue declined 0.45% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Return analysis
Company profile
TruBridge, Inc. delivers a comprehensive suite of healthcare solutions and services to community hospitals, clinics, and various medical facilities, both within the United States and globally.
Market multiples
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
7
Buy
15
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Actuals vs estimates by quarter, or any quarter against the same one a year earlier.
Next report
Aug 6, 2026
Q2 FY26 · EPS est $0.57 · Revenue est $88.2M
Same quarter, year over year
FY26 YTD +63.9%Each cell vs the same quarter a year earlier (the cell below) · Q1 combined $0.59 vs $0.36 · up year over year
Q1
Q2
Q3
Q4
FY total
FY26
—
—
—
FY25
FY24
FY23
—
—
Fiscal year totals
- FY25
- $2.57
- n/m
- FY24
- $0.19
- —
n/m: last year’s figure was zero, a loss or too small to compare against
Q1 FY26
Reported May 8, 2026 · Latest
HoverTap a cell to inspect
Actual
$0.59
Estimate
$0.51
Year over year
+63.9%
Vs prior quarter
-25.3%
Institutional Sentiment
TruBridge, Inc. · TBRG
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.